Mesa Laboratories supplies life-science tools and critical quality-control products used to verify sterilization, process integrity, and product safety. Its portfolio includes biological and chemical indicators and related instruments for pharmaceutical, medical-device, healthcare, and industrial customers. The business is built around recurring, compliance-driven demand where accurate monitoring and validation are essential.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 62.1 | — | -7.1 | — |
| Q2 2025 | 59.5 | — | 4.7 | — |
| Q3 2025 | 60.7 | — | 2.5 | — |
| Q4 2025 | 65.1 | — | 3.6 | — |
| Q1 2026 | 63.7 | 2.6% | -4.1 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: SOPHiA GENETICS SA (SOPH), REalloys Inc. (ALOY), Einride AB (ENRD), Donegal Group Inc. (DGICA), PRA Group, Inc. (PRAA), BridgeBio Oncology Therapeutics, Inc. (BBOT)